Remodulin, a drug for treatment of high blood pressure produced by United Therapeutics, has been approved for use in Australia by the Australian Therapeutic Goods Administration.
Remodulin is already used in the United States, Canada and Israel. The company is seeking approval in several other European countries as well as Taiwan and Brazil.
United Therapeutics: www.unither.com
